Metabolomics is scientific term in which technical study of metabolites which is small molecules, biological cell, biofluids, tissue and organs. Metabolomics is also used to explain rising skill of measurement and study of metabolites like sugar & fat within the cell of organs by definite period and in definite situation. Metabolomics is having the common characteristics with computer science technology, mathematics, chemistry and biology. Metabolomics is important to medical doctor for the reason that it can guide to progress in the finding and treatments of person diseases. Analytical equipments and different software are very important object in metabolomics field.
The metabolomics market is projected to cross USD 2.0 Billion in the given forecasted period. North America contributed up to 45% of market share making it a market leader in metabolomics market. Europe is second largest market with up to 39% of the market share. Asia-Pacific will grow at remarkable CAGR i.e. 24% during the forecast period. Increasing penetration of pharmaceutical products is stimulating the APAC market.
The major driving factors of metabolomics market are as follows:
o Rising research funding and administration support drives the market growth.
o Use in biotechnology and pharmaceutical area spur the metabolomics research.
o Growing requirement of personalized medication within healthcare industry.
o Increasing requirement for toxicity equipment.
The restraints factors of metabolomics market are as follows:
o Data examination and data processing.
o Low acceptance rate.
The metabolomics market is segmented on the lines of its technique, application and indication. The metabolomics market is segmented on the lines of its technique like separation techniques and detection techniques. The separation techniques is further divided into gas chromatography (GC), capillary electrophoresis (CE), high performance liquid chromatography (HPLC) and ultra performance liquid chromatography (UPLC). Detection techniques covers nuclear magnetic resonance spectroscopy (NMR), mass spectrometry (MS) and surface based mass analysis.The metabolomics market is segmented on the lines of its applications into biomarker, discovery, drug discovery/drug assessment, toxicology testing and nutrigenomics.Under indication segmentation it covered oncology, neurology and cardiology.The metabolomics market is geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geography market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.
This report provides:
1) An overview of the global market for metabolomics and related technologies.
2) Analyses of global market trends, with data from 2021, estimates for 2022 and 2023, and projections of compound annual growth rates (CAGRs) through 2028.
3) Identifications of new market opportunities and targeted promotional plans for metabolomics.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
REPORT SCOPE:
The scope of the report includes a detailed study of global and regional markets for various types of metabolomics with the reasons given for variations in the growth of the industry in certain regions.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include:
• Thermo Fisher Scientific Inc.
• Danaher Corporation
• Waters Corporation
• Agilent Technologies
• Metabolon, Inc.
• Shimadzu Corporation
• Bruker Corporation
• Biocrates Life Sciences AG.
Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.
The Metabolomics Market has been segmented as below:
By Technique Analysis
Separation Techniques
Gas Chromatography (GC)
Capillary Electrophoresis (CE)
High Performance Liquid Chromatography (HPLC)
Ultra Performance Liquid Chromatography (UPLC)
Detection Techniques
Nuclear Magnetic Resonance Spectroscopy (NMR)
Mass Spectrometry (MS)
Surface Based Mass Analysis
By Application Analysis
Biomarker Discovery
Drug Discovery/Drug Assessment
Toxicology Testing
Nutrigenomics
Others
By Indication Analysis
Oncology
Neurology
Cardiology
Others
By Regional Analysis
North America
Europe
Asia-Pacific
Rest of the World
Reasons to Buy this Report:
1) Obtain the most up to date information available on all active and planned metabolomics industry globally.
2) Identify growth segments and opportunities in the industry.
3) Facilitate decision making on the basis of strong historic and forecast of metabolomics industry and unit capacity data.
4) Assess your competitor’s refining portfolio and its evolution.
Customization:
We can offer you custom research reports as per client’s special requirements.
Below are our New Reports :-
Bioprocess Optimization and Digital Bio-manufacturing market
1 INTRODUCTION
1.1 Key Take Aways
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Research Methodology
1.5.1 Market Size
1.5.2 Market Share
1.5.3 Key Data Points From Secondary Sources
1.5.4 Key Data Points From Primary Sources
2 Research Methodology
2.1 Research Approach
2.1.1 Secondary Research
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Research
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.2 Market Size Estimation
2.3 Market Breakdown and Data Triangulation
2.4 Market Share Estimation
2.5 Assumptions for the Study
3 Executive Summary
4 Premium Insights
4.1 Metabolomics Market Overview
4.2 Asia-Pacific: Metabolomics Separation Tools Market, By Type
4.3 Geographic Snapshot: Metabolomics Market
4.4 Geographic Mix: Metabolomics Market
4.5 Metabolomics Market: Developing vs Developed Markets
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Market Drivers
5.2.1.1 Availability of Government and Private Funding
5.2.1.2 Increasing Pharmaceutical and Biotech R&D Expenditure
5.2.1.3 Technological Advancements
5.2.1.4 Growing Demand for Personalized Medicine
5.2.1.5 Increasing Use of Metabolomics in Toxicology Testing
5.2.2 Key Market Restraints
5.2.2.1 Issues Related to Data Examination and Processing
5.2.2.2 High Cost of Tools and Instruments
5.2.3 Key Market Opportunities
5.2.3.1 Biomarker Development
5.2.3.2 Rapid Growth Opportunities in Emerging Markets
5.2.4 Key Challenges
5.2.4.1 Complexity and Diversity of Biological Samples
5.2.4.2 Dearth of Skilled Researchers
6 Industry Insights
6.1 Introduction
6.2 Industry Trends
6.2.1 Increasing Adoption of Hyphenated Technologies
6.2.2 Tie-Ups Between Instrument Manufacturers and Research Laboratories/Academic Institutions
6.3 Regulatory Analysis
7 Technology Investment Potential
7.1 Introduction
7.2 Investment Client Networks
7.3 Funding Bodies/Initiatives (2012–2016)
7.4 Analysis of Potential Areas for Technology Investment Using Strategic Evaluation
7.4.1 Parameters Considered for Emerging Opportunity Evaluation
7.4.1.1 Level of Attractiveness
7.4.1.2 Probability of Success
7.4.2 Opportunity Strategic Evaluation Analysis
7.4.3 Description of Opportunities
7.4.3.1 Viable (Quadrant 1) – Biomarker Discovery and Lead Optimization in Drug Discovery
7.4.3.1.1 Biomarker Discovery
7.4.3.1.2 Lead Optimization in Drug Discovery
7.4.3.1.3 Toxicity Testing
7.4.3.2 Promising (Quadrant 2) – Companion Diagnostics for Personalized Medicine and Nutrigenomics
7.4.3.2.1 Companion Diagnostics for Personalized Medicine
7.4.3.2.2 Nutrigenomics
7.4.3.2.3 Agriculture
7.4.3.3 Challenging (Quadrant 3) – Environmental Metabolomics
7.4.3.3.1 Environmental Metabolomics
7.4.3.3.2 Functional Genomics
8 Global Metabolomics Market, By Product and Service
8.1 Introduction
8.2 Metabolomics Instruments
8.2.1 Separation Tools
8.2.1.1 High-Performance Liquid Chromatography
8.2.1.2 Gas Chromatography
8.2.1.3 Ultra-Performance Liquid Chromatography
8.2.1.4 Capillary Electrophoresis
8.2.2 Detection Tools
8.2.2.1 Mass Spectrometry
8.2.2.2 Nuclear Magnetic Resonance Spectroscopy
8.2.2.3 Surface-Based Mass Analysis
8.3 Metabolomics Bioinformatics Tools and Services
8.3.1 Bioinformatics Tools & Databases
8.3.2 Bioinformatics Services
9 Global Metabolomics Market, By Application
9.1 Introduction
9.2 Biomarker Discovery
9.3 Drug Discovery
9.4 Toxicology Testing
9.5 Nutrigenomics
9.6 Functional Genomics
9.7 Personalized Medicine
9.8 Other Applications
10 Global Metabolomics Market, By Indication
10.1 Introduction
10.2 Cancer
10.3 Cardiovascular Disorders
10.4 Neurological Disorders
10.5 Inborn Errors of Metabolism
10.6 Other Indications
11 Global Metabolomics Market, By Region
11.1 Introduction
11.2 North America
11.2.1 U.S.
11.2.2 Canada
11.3 Europe
11.3.1 Germany
11.3.2 U.K.
11.3.3 France
11.3.4 Italy
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia-Pacific
11.4.1 Japan
11.4.2 China
11.4.3 India
11.4.4 Rest of APAC
11.5 Latin America
11.5.1 Brazil
11.5.2 Mexico
11.5.3 Rest of Latin America
11.6 Middle East and Africa
12 Competitive Landscape
12.1 Overview
12.2 Product Portfolio Analysis
12.3 Market Share Analysis
12.4 Competitive Situations and Trends
12.4.1 Product Launches and Enhancements
12.4.2 Partnerships, Agreements, Collaborations, and Alliances
12.4.3 Expansions
12.4.4 Acquisitions and Divestitures
The Metabolomics Market has been segmented as below:
By Technique Analysis
Separation Techniques
Gas Chromatography (GC)
Capillary Electrophoresis (CE)
High Performance Liquid Chromatography (HPLC)
Ultra Performance Liquid Chromatography (UPLC)
Detection Techniques
Nuclear Magnetic Resonance Spectroscopy (NMR)
Mass Spectrometry (MS)
Surface Based Mass Analysis
By Application Analysis
Biomarker Discovery
Drug Discovery/Drug Assessment
Toxicology Testing
Nutrigenomics
Others
By Indication Analysis
Oncology
Neurology
Cardiology
Others
By Regional Analysis
North America
Europe
Asia-Pacific
Rest of the World
SUBSCRIBE TO OUR NEWSLETTERS
